Relationships & Support · NCI Cancer Currents Blog · October 8, 2026

Taking on the RAS Challenge

For decades, RAS proteins were considered nearly impossible to target with drugs. NCI-supported basic research and the RAS Initiative helped lay the groundwork for new RAS inhibitors that are now benefiting patients and advancing through clinical trials.

Originally published by NCI Cancer Currents Blog. We curate and add context; they did the reporting.

Related learning